Upload
desi-adiyati
View
213
Download
0
Embed Size (px)
Citation preview
8/9/2019 JURDING OBGYN Salfingektomi
1/10
GYNECOLOGY
A retrospective analysis of the effect ofsalpingectomy on serum antiMullerian
hormone level and ovarian reserveXu-ping Ye, BS; Yue-zhou Yang, MS; Xiao-xi Sun, MD
OBJECTIVE:To determine whether previous salpingectomy is asso-
ciated with serum antiMullerian hormone (AMH) level and ovarian
reserve in women under 40 years presenting for in vitro fertilization
and embryo transfer.
STUDY DESIGN: We retrospectively compared serum AMH levels
measured on the ovulation induction initiation day in patients with
unilateral salpingectomy, bilateral salpingectomy, and no tubal sur-
gery, and examined the relationship with length of time after surgery
and in vitro fertilization and embryo transfer parameters.
RESULTS:A total of 198 women were included; 83 received unilateral
salpingectomy, 41 bilateral salpingectomy, and 74 no tubal surgery.
The baseline characteristics of the groups were similar. The mean
AMH level was significantly higher in women without tubal surgery as
compared with those with bilateral salpingectomy (183.48 vs
127.11 fmol/mL; P .037). The mean follicle stimulation hormone
level was significantly lower in women without surgery as compared
with those with bilateral salpingectomy (7.85 vs 9.13 mIU/mL;
P .048). No significant differences in duration of gonadotropin
therapy, amount of gonadotropin used, estradiol level on the human
chorionic gonadotropin injection day, thickness of the endometrium,
number of oocytes retrieved, number of 2-pronuclei, viable embryos,
and good quality embryos were found between the 3 groups. AMH
level was not correlated with the number of oocytes or age in women
that had undergone unilateral or bilateral salpingectomy.
CONCLUSION:Salpingectomy is associated with decreased AMH level
and increased follicle stimulation hormone in women seeking in vitro
fertilization, though AMH level is not correlated with the number of
oocytes retrieved in patients that have undergone unilateral or bilateral
salpingectomy. These results suggest that salpingectomy is associ-
ated with decreased ovarian reserve.
Key words:AMH, antiMullerian hormone, IVF-ET, ovarian reserve,
salpingectomy
Cite this article as: Ye X, Yang Y, Sun X. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. Am J Obstet
Gynecol 2015;212:53.e1-10.
I t is generally recognized that removalof a hydrosalpinx can increase theimplantation rate of in vitro fertilization
and embryo transfer (IVF-ET).1,2 How-ever, whether salpingectomy affects
ovarian reserve is uncertain, with some
studies suggesting that salpingectomydeceases ovarian reserve,3-5 and other
studies indicating that it has no effecton ovarian reserve.6-9 Various studies,
however, have used different measures of
ovarian reserve including the duration of
gonadotropin stimulation, amount ofgonadotropin used, number of follicles,
number of oocytes retrieved, fertilizationrate, implantation rate, clinical preg-
nancy rate, live birth rate, and anti-Mllerian hormone (AMH) level.
AMH is a glycoprotein dimer secreted
primarily by granulocytes of preantralfollicles and small antral follicles.10
AMH levels are relatively constant thr-oughout the menstrual cycle,11 correlate
with the number of follicles and ovarian
reserve,12-14 and are predictive of bothover and poor response to controlled
ovarian stimulation.15,16 For these rea-
sons, AMH levels can be used to evalu-ate changes in ovarian reserve after
salpingectomy.The purpose of this study was to
determine whether previous salpingec-
tomy is associated with serum AMH leveland ovarian reserve in women under
40 years of age presenting for IVF-ET.
PATIENTS ANDMETHODSPatients
IVF-ET patients who visited Shanghai
Ji Ai Genetics and IVF Institute andthe Obstetrics and Gynecology Hospital
of Fudan University between October
2012 and May 2013 were eligible for in-clusion in this study. Inclusion criteria
were age
8/9/2019 JURDING OBGYN Salfingektomi
2/10
centrifuged for 5 minutes, and the su-pernatant serum was collected and
stored at 20 C. Before testing, the
sample was thawed and vortexed.Estradiol (E2), progesterone, luteinizing
hormone, and follicle stimulating hor-
mone (FSH) levels were measured with aBeckman Acoulter Access automated
chemiluminescence immunoassayanalyzer with reagent kits from Beckman
(BeckmaneCoulter Inc., Brea, CA).Testing was performed according to the
manufacturers instructions. AMH levels
were measured by an enzyme linkedimmunosorbent assay using a Bio-Rad
iMark microplate absorbance readerwith reagent kits from Bio-Rad (Bio-Rad
Laboratories Inc, Hercules, CA). Per the
manufacturer, the interassay coef
cientof variability is 10%, and the intraassay
coefcient of variability is 15%.
Determination of antral follicle count
On the third day of menstruation (IVF-ET initiation day), transvaginal sonog-
raphy was performed to evaluate the
status of the uterus and ovaries, measurethe ovarian size, and determine the
antral follicle count (AFC). A PhilipsHDII ultrasonography machine (Philips,
Amsterdam, the Netherlands) was usedat a probe frequency of 3w7 MHz.
Ovulation induction and IVF protocols
Short controlled ovarian
hyperstimulation protocolDaily subcutaneous triptorelin 0.1 mg
was given from the third day of men-
struation to the day of human chorionicgonadotropin (hCG) injection. Gonad-
otropin 75-300 IU/day by injection was
started on the fourth day, and adjusted
according to ultrasonography resultsand serum E2level.
Minimal ovarian stimulation protocol
Oral clomiphene 50-100 mg was given
from the third day of menstruation tothe day of hCG injection. Daily humanmenopausal gonadotropin 75-150 IU
by injection was given starting on the
fth day of clomiphene. When 1 domi-nant follicle reached 18 mm in diameter,
or 2 follicles reached 16 mm in diameter,
intramuscular injection of hCG 3000-10000 IU was given. Oocytes were
retrieved under transvaginal ultraso-nography guidance within 34-36 hours
of hCG injection.
IVFQuality sperm was selected for IVF/
intracytoplasmic sperm injection. Eigh-teen hours after fertilization, the oocyte
was observed to conrm the formation
of a pronucleus. After 3 days of culture,the embryo was observed and scored
under a microscope.
Evaluation of embryo qualityEmbryos of class I-III were considered
viable. Goodquality embryos were denedas having a normal cleavage rate, even-
sized blastomeres, and fragments .05). The mean AMH level was signi-
cantly higher in women without tubalsurgery as compared with those with
bilateral salpingectomy (183.48 vs
127.11 fmol/mL, P .037). The meanFSH level was signicantly lower in
women without surgery as comparedwith those with bilateral salpingectomy
(7.85 vs 9.13 mIU/mL, P .048). Themean duration of primary infertility was
signicantly higher in women without
surgery as compared with those withunilateral and bilateral salpingectomy
(3.6 vs 0.31 and 0.82 years, P < .001).The reasons for having surgery were
signicantly different between the uni-
lateral and bilateral salpingectomygroups. The percentage of patients with
an ectopic pregnancy was greater in the
unilateral salpingectomy group, and thepercentage of patients with a hydro-
salpinx was greater in the bilateral sal-pingectomy group (Table 1).
The comparisons of treatment-related
factors between the three groups areshown inTable 2. No signicant differ-
ences in duration of gonadotropin ther-
apy, amount of gonadotropin used,
E2 level on the hCG injection day,thickness of the endometrium, numberof oocytes retrieved, number of 2-pro-
nuclear zygote (2PN), viable embryos,and good quality embryos were found
between the 3 groups (all,P> .05).
Correlation between AMH level
and time after surgery and numberof oocytes
The correlations between AMH level and
time after surgery, number of oocytes,
and age for women with a unilateralsalpingectomy are shown in Figure 1,
and the correlations for women with abilateral salpingectomy are shown in
Figure 2. For women with a unilateral
salpingectomy, a signicant linear cor-relation was found between AMH leveland time after surgery (r 0.399, P